TXG
10x Genomics Inc Earnings
$16.06
Earnings Summary
Revenue | $149Mn |
Net Profits | $-27.47Mn |
Net Profit Margins | -18.44% |
10x Genomics Inc’s revenue fell -1.75% since last year same period to $149Mn in the Q3 2025. On a quarterly growth basis, 10x Genomics Inc has generated -13.83% fall in its revenue since last 3-months.
10x Genomics Inc’s net profit jumped 23.16% since last year same period to $-27.47Mn in the Q3 2025. On a quarterly growth basis, 10x Genomics Inc has generated -179.54% fall in its net profits since last 3-months.
10x Genomics Inc’s net profit margin jumped 21.79% since last year same period to -18.44% in the Q3 2025. On a quarterly growth basis, 10x Genomics Inc has generated -192.3% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.22 |
EPS Estimate Current Year | -0.22 |
10x Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.22 - a -218% fall from last quarter’s estimates.
10x Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.22.
Key Ratios
Earning Per Share (EPS) | 0 |
10x Genomics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2025. This indicates that the 10x Genomics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-09 | -0.47 | -0.28 | 40.43% |
2026-02-18 | -0.22 | 0 | 100% |
2025-08-08 | -0.31 | 0.28 | 190.32% |
2025-11-07 | -0.07 | -0.02 | 67.43% |
